![Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-15436-0/MediaObjects/41467_2020_15436_Fig1_HTML.png)
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications
![Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-020-0755-1/MediaObjects/41591_2020_755_Fig2_HTML.png)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
![Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality | Journal of the American Chemical Society Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.2c11706/asset/images/large/ja2c11706_0008.jpeg)
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality | Journal of the American Chemical Society
![Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer's disease | Signal Transduction and Targeted Therapy Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer's disease | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00416-z/MediaObjects/41392_2020_416_Fig1_HTML.png)
Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer's disease | Signal Transduction and Targeted Therapy
![Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine](https://www.thelancet.com/cms/attachment/b5ba9d05-7ab4-42c3-9c4e-bd943c66a08a/gr1_lrg.jpg)
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Fluorescence Lifetime Imaging of p-tau Protein in Single Neuron with a Highly Selective Fluorescent Probe | Analytical Chemistry
![Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867412002164-fx1.jpg)
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect
![Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0197458020303973-fx1.jpg)
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect
![P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13195-022-01038-z/MediaObjects/13195_2022_1038_Fig1_HTML.png)
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
![BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease | Barcelona Beta BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease | Barcelona Beta](https://www.barcelonabeta.org/sites/default/files/styles/noticia_ampliada/public/2020-11/Cambios%20de%20los%20nuevos%20biomarcadores%20BBRC.jpg?itok=BPZreRt0)
BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease | Barcelona Beta
![Frontiers | Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability Frontiers | Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability](https://www.frontiersin.org/files/Articles/397506/fncel-12-00338-HTML/image_m/fncel-12-00338-g001.jpg)
Frontiers | Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
![Frontiers | Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo Frontiers | Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo](https://www.frontiersin.org/files/Articles/447903/fnagi-11-00034-HTML/image_m/fnagi-11-00034-g001.jpg)
Frontiers | Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
![Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau | EMBO Molecular Medicine Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/a9694381-cab2-47f7-adec-05c27fadc4ff/emmm202114022-abs-0001-m.jpg)
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau | EMBO Molecular Medicine
![STZ effect on p-tau in hippocampus. (a) Representative immunoblots of... | Download Scientific Diagram STZ effect on p-tau in hippocampus. (a) Representative immunoblots of... | Download Scientific Diagram](https://www.researchgate.net/publication/314652025/figure/fig3/AS:471118491459587@1489334809728/STZ-effect-on-p-tau-in-hippocampus-a-Representative-immunoblots-of-p-tau-and-total.png)